Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus plantarum 299v in Diabetic Macular Edema
NCT07383701Phase 2Recruiting
- Sponsor
- Massachusetts Eye and Ear
- Start
- Jun 2026
- Primary completion
- Jun 2027
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of lactobacillus plantarum 299v in diabetic macular edema (DME), sponsored by Massachusetts Eye and Ear. Started Jun 2026; status: recruiting.
02
Drugs
lactobacillus plantarum 299v
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT07383701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07383701.